|1.||Light, R W: 11 articles (08/2003 - 01/2000)|
|2.||Vargas, Francisco S: 9 articles (11/2009 - 12/2002)|
|3.||Marchi, Evaldo: 9 articles (11/2009 - 12/2002)|
|4.||Lee, Y C Gary: 8 articles (01/2014 - 12/2003)|
|5.||Cramer, Daniel W: 7 articles (03/2014 - 05/2005)|
|6.||Light, Richard W: 7 articles (07/2012 - 01/2002)|
|7.||Antonangelo, Leila: 7 articles (11/2009 - 12/2002)|
|8.||Teixeira, Lisete R: 7 articles (11/2009 - 12/2002)|
|9.||Davies, Robert J O: 6 articles (06/2012 - 12/2003)|
|10.||Vargas, F S: 6 articles (02/2010 - 09/2000)|
|1.||Malignant Pleural Effusion
12/01/2006 - "Our study confirms that intrapleural talc carries good results in the treatment of malignant pleural effusion. "
01/01/2013 - "While talc is now accepted to be a worldwide gold-standard sclerosing agent for treating malignant pleural effusion, it is not yet approved in Japan. "
04/01/2007 - "The present study evaluated the angiogenic balance in the pleural space in patients with malignant pleural effusions (MPE) following talc insufflation. "
12/01/1996 - "We designed a prospective, randomized study to compare video-assisted thoracoscopic talc insufflation with bedside talc slurry in the treatment of malignant pleural effusion. "
12/01/2014 - "This case series summarizes the safety and efficacy data of all patients (24) with a symptomatic malignant pleural effusion who underwent talc pleurodeses via IPCs between December 2010 and July 2013. "
10/01/1994 - "We conclude from these observations that the insufflation of 2 g of talc into the pleural space is a safe effective treatment for control of recurrent spontaneous pneumothorax."
11/01/2004 - "Feasibility, safety and efficacy of VATS for management of recurrent primary spontaneous pneumothorax following thoracoscopic talc poudrage are strongly suggested."
07/01/2012 - "The aim of this study was to compare talc poudrage and pleural abrasion in the treatment of spontaneous pneumothorax. "
07/01/2012 - "Comparative study of talc poudrage versus pleural abrasion for the treatment of primary spontaneous pneumothorax."
10/01/2011 - "A complete response was obtained in all patients with pneumothorax in both the iodopovidone and talc groups. "
|3.||Pleural Effusion (Pleural Effusions)
07/01/1995 - "Recent study results indicate that intrapleural instillation of iodized talc is an adequate and effective treatment for control of neoplastic or benign pleural effusion."
06/01/1995 - "The intrapleural insufflation of talc was effective in preventing recurrence of pleural effusion. "
05/01/1992 - "These observations indicate that intrapleural instillation of a slurry of iodized talc is a safe, adequate, and effective treatment for control of neoplastic or benign pleural effusions."
12/01/2011 - "Not more effective than talc in preventing recurrent pleural effusions, based on a review with meta-analysis of 7 trials in 256 patients. "
12/01/1994 - "The objective of this study is to present our experience with a low dose of aerosolized talc for controlling nonmalignant pleural effusions. "
07/01/2000 - "Thoracoscopy and talc poudrage in the management of hepatic hydrothorax."
11/01/1996 - "Video-assisted thoracic surgery with talc poudrage is an effective and safe procedure with minimal morbidity for management of hydrothorax secondary to CAPD. "
08/01/2006 - "Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax."
09/01/2004 - "Talc pleurodesis can be offered to patients with hepatic hydrothorax. "
05/01/2004 - "Three patients whose hydrothorax was refractory to medical treatment were treated by pleurodesis with talc. "
|5.||Dyspnea (Shortness of Breath)
06/13/2012 - "There was a statistically significant improvement in dyspnea in the IPC group at 6 months, with a mean difference in VAS score between the IPC group and the talc group of −14.0 mm (95% CI, −25.2 to −2.8 mm; P = .01). "
06/13/2012 - "Dyspnea improved in both groups, with no significant difference in the first 42 days with a mean VAS dyspnea score of 24.7 in the IPC group (95% CI, 19.3-30.1 mm) and 24.4 mm (95% CI, 19.4-29.4 mm) in the talc group, with a difference of 0.16 mm (95% CI, −6.82 to 7.15; P = .96). "
10/01/1995 - "Although her shortness of breath was relieved following VAT decortication and talc insufflation, at 3 months she was found to have a 2.5-cm subcutaneous nodule at the camera port site which on biopsy was confirmed to be metastatic in nature. "
01/01/2010 - "Video-assisted thoracoscopic talc poudrage is an effective and safe procedure that yields a high rate of successful pleurodesis and achieves long-term control with marked dyspnea decrease."
06/01/2001 - "The VATS talc pleurodesis resulted in clinically significant improvement of dyspnea in 92.2% of the patients. "
|6.||Thymidine Monophosphate (TMP)
|7.||raltitrexed (D 1694)
|8.||Opioid Analgesics (Opioids)
|9.||Staphylococcal Protein A (A, Protein)
|3.||Chest Tubes (Chest Tube)
|5.||Palliative Care (Palliative Medicine)